Proinflammatory Cytokines Increase Glial Fibrillary Acidic Protein Expression in Enteric Glia
Overview
Affiliations
Background: Enteric glia protect the integrity of the gut, as loss of enteric glial fibrillary acidic protein (GFAP) positive (+) glia leads to a haemorrhagic jejunoileitis. Crohn's disease (CD) and necrotising enterocolitis (NEC) show pathological changes in enteric glia. Therefore, factors controlling GFAP+ enteric glia are of great interest. The aim of the present study was to characterise enteric glia and determine the effect of interleukin 1beta (IL-1beta), interleukin 4 (IL-4), tumour necrosis factor alpha (TNF-alpha), and lipopolysaccharides (LPS) on cultured enteric glia.
Methods: Dissected rat colon and cultured enteric glia cells were double labelled with anti-GFAP and anti-S-100 antibodies. For regulatory studies, enteric glia cells were treated with cytokines and LPS. Proliferation was assayed using bromodeoxyuridine (BrdU) and mitosis of enteric glia was blocked by demecolcine.
Results: We were able to distinguish GFAP negative (-) from GFAP+ glia subtypes in situ and in primary cultures. Incubation of cells with IL-1beta, TNF-alpha, and LPS led to a significant increase in GFAP+ enteric glia while IL-4 had no effect on GFAP expression. After incubation with IL-1beta, total intracellular GFAP of enteric glia cells was increased. Upregulation of GFAP+ enteric glia could also be observed after stimulation with IL-1beta on blocking mitosis. BrdU uptake in stimulated enteric glia showed no increased proliferation rate.
Conclusions: Two different types of enteric glia based on GFAP expression exist in the gut. Proinflammatory cytokines and LPS cause a dramatic increase in GFAP+ enteric glia. This suggests that cytokines play an important role in controlling GFAP+ enteric glia which might in turn be involved in modulating the integrity of the bowel during inflammation.
Sun Q, Li B, Li D, Wang X, Wang Q, Jiang Z J Transl Med. 2025; 23(1):93.
PMID: 39838431 PMC: 11748877. DOI: 10.1186/s12967-025-06085-2.
Role of Inflammation and the NF-κB Signaling Pathway in Hirschsprung's Disease.
Elkrewi E, Al Abdulqader A, Khasanov R, Maas-Omlor S, Boettcher M, Wessel L Biomolecules. 2024; 14(8).
PMID: 39199380 PMC: 11352745. DOI: 10.3390/biom14080992.
Rajala A, Rajala R, Bhat M, Eminhizer M, Hao J, Du J Cell Death Dis. 2024; 15(8):577.
PMID: 39117618 PMC: 11310310. DOI: 10.1038/s41419-024-06924-y.
Balan I, Grusca A, Chery S, Materia B, OBuckley T, Morrow A Life (Basel). 2024; 14(7).
PMID: 39063614 PMC: 11277648. DOI: 10.3390/life14070860.
Enteric glia as friends and foes of the intestinal epithelial barrier function.
Bali V, Grubisic V Front Immunol. 2024; 15:1394654.
PMID: 38873614 PMC: 11169670. DOI: 10.3389/fimmu.2024.1394654.